Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Neurology|July 30, 2021
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revisionPeter Y K Van den Bergh, Pieter A van Doorn, Robert D M Hadden, et al.
Journal of the Peripheral Nervous System : JPNS|June 4, 2021
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revisionPeter Y K Van den Bergh, Pieter A van Doorn, Robert D M Hadden, et al.
Journal of the Peripheral Nervous System : JPNS|October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndromePieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.
European Journal of Neurology|October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndromePieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.
Brain Communications|January 12, 2023
Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4Marloes Stam, Camiel A Wijngaarde, Bart Bartels, et al.
European Journal of Neurology|September 5, 2024
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseasesKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Neurology. Clinical Practice|April 12, 2021
Facial Onset Sensory and Motor Neuronopathy: New Cases, Cognitive Changes, and PathophysiologyEva M J de Boer, Andrew W Barritt, Marwa Elamin, et al.
Brain Communications|September 21, 2020
<i>ATXN1</i> repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalizationGijs H P Tazelaar, Steven Boeynaems, Mathias De Decker, et al.
BMC Medicine|March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseasesLuuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Journal of Autoimmunity|January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinationsKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Pageof 7